Sonoma Pharmaceuticals
SNOA
25 hedge funds and large institutions have $1.89M invested in Sonoma Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
19% more funds holding
Funds holding: 21 → 25 (+4)
4% more capital invested
Capital invested by funds: $1.82M → $1.89M (+$69K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$377K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$21.4K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$19.5K |
| 4 |
RC
RegentAtlantic Capital
Morristown,
New Jersey
|
+$15.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$6.5K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$2.79K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$2.79K |
| 4 |
Goldman Sachs
New York
|
-$2.79K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.86K |
SNOA Hedge Fund Activity: Q1 2016 in Review
25 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q1 2016, worth a combined $1.89M — up 3.8% from $1.82M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SNOA positions and 2 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $377K. The largest seller was Citadel Advisors, cutting an estimated $6.5K.
- 25 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q1 2016, up from 21 in Q4 2015.
- Funds reported $1.89M of Sonoma Pharmaceuticals stock for Q1 2016, up 3.8% quarter-over-quarter.
- 6 funds opened new Sonoma Pharmaceuticals positions in Q1 2016 and 2 closed out, a net change of +4 holders.
- The largest Sonoma Pharmaceuticals buyer in Q1 2016 was Anson Funds Management, an estimated $377K added.
- The largest Sonoma Pharmaceuticals seller in Q1 2016 was Citadel Advisors, an estimated $6.5K sold.
Based on aggregated 13F filings for Q1 2016.